The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World Evidence-Based Healthcare (EBHC) Day blog, introducing ERA4TB’s aims and work. This piece reflects on how partnerships…
TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the European Regimen Accelerator for Tuberculosis (ERA4TB) project. Funded by the European Union Innovative Medicines Initiative…
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in 2019, according to preliminary data compiled by the World Health Organization (WHO) from over 80…
Innovative Medicines Initiative Launches European Regimen Accelerator For Tuberculosis (ERA4TB) project.
Know how accelerate the development of new treatment regimens for tuberculosis, discover our project
The Project
